Burisma Holding: Joe Biden, Hunter Biden, John Kerry,

New Post Public Reply Private Reply Replies (1) Message Board
Lmcat
894
Burisma Holding: Joe Biden, Hunter Biden, John Kerry, Aleksander Kwasniewski, Mykola Zlochevskyi Devon Archer Case

WSJ

Frequent readers of this site aren’t surprised that Devon Archer , first written about back in October 2014, as Hunter Biden’s partner at a US investment firm, Rosemont Seneca Partners and Director at Burisma Holdings Ukraine Natural Gas Production – Oil & Gas Company in Ukraine, again with his buddy Hunter Biden (yep, VP Joe Biden’s coke snorting, kicked out of the military’s son) is now accused by SEC of selling fake bonds, with six others.

Odd, Archer and H. Biden appear to do everything in business together, yet Hunter Biden’s name is missing from the list of names. Hmmm.

October 25, 2015

Updated: The former President of Poland (1995-2005) Aleksander Kwasniewski may not hold significance for most of us in this country; however, who and why he’s linked to Vice President Joe Biden, his son Hunter Biden and Senator John Kerry should be of interest.
It’s likely in part why Biden decided not to run for President in 2016.

Keep in mind an interesting point from Gods Among Mere Mortals when an organization is employing tactics from The Sociopathic Business Model™ executives are often put in positions that are far above their skill level as a means of later manipulating the grateful executives.

This allows the board to later pull the strings without any pushback from the executives. So when a company that’s been around since 2002, Burisma Holdings, has a board comprised of members all appointed from 2013-2104 this implies the board is in place for later manipulation.

Burisma-Holdings-Board-2.jpg

So who and why would anyone want to later manipulate the board of Burisma Holdings?

Let’s start with the two known Americans on the list:

Hunter Biden, yes the coke snorting kicked out of the Navy Reserves after one month, son of Vice President of the United States Joe Biden

and Devon Archer ,Hunter Biden’s partner at a US investment firm, Rosemont Seneca Partners (weird- that’s missing from the Burisma Holdings Board page-fixed that for them), and fund manager for Senator John Kerry and his wife Theresa Heinz Kerry, the widow of Henry Heinz III. Yes, those Heinz.

The Wall Street Journal, citing “people familiar with the matter” reported that Biden was given a drug test in June 2013 that tested positive for cocaine. Hunter Biden received one waiver for his age (he was 42 at the time) and a second waiver because of a “drug-related incident when he was a young man.” A Commander said Biden knew the drug test was coming

Here’s the thing, guys like this, don’t leave anything off their bio (if they took an off-color shit-it’d likely be on there), we’re talking egos that can eclipse the sun.

It’s inconsistent and contradictory language to action from Team Hunter not to have Rosement Sceneca Partners on his Burisma Holdings bio for board members.

If something’s left off it’s usually to manipulate facts or distance SEO from unethical or illegal activity as we saw with Johnson & Johnson CEO Alex Gorsky while he was President and VP of Sales and Marketing at Janssen Pharmaceuticals the makers of Risperdal that resulted in a $2.2 billion federal fine for off-label marketing promotion and illegal kick-backs (and oh yeah- 31 children died, 14-year old boys grew breasts and another 1,207 children suffered serious issues).

Mr. Gorsky’s Johnson & Johnson bio removed VP of Sales and Marketing from the Janssen part of his company website-guess he didn’t want to be linked to baby-killing. Kinda makes you say “Baby shampoo? Or baby killers?“Doesn’t it? Is it just me, or do you hear that in Nancy Grace’s voice?

So if Hunter Biden’s latest illegal activity (and his previous “drug-related incident”) is an indication and fact based evidence over time is a good indicator of the future it looks like Hunter is no stranger to unethical/illegal activity and just a place-holder for far bigger manipulations much higher up the food chain; and, we already know my thoughts on Senator John Kerry.

Again, don’t get hung up on titles like Republican or Democrat and look at the actions and not the political PRSpin.

We’ll PRSpinUnSpun this one over time, but this page doesn’t work for those unwilling to look at fact-based evidence in order to create greater positive change.

It is strange that Vice President Biden, who doesn’t like to miss a press opportunity, not unlike all politicians, has refused to comment on his son’s now obvious cocaine habit. Perhaps Joe Biden’s been aware of his son’s problems and is why he’s been so vocal against drugs.

Updated: October 25, 2015

The former President of Poland (1995-2005) Aleksander Kwasniewski may not hold significance for most of us here in the U.S.; however, who and why he’s linked to Vice President Joe Biden, his son Hunter Biden and Senator John Kerry should be of interest.

If we work within The Sociopathic Business Model™and look for inconsistent & contradictory language to action, Hunter on a board of any kind is nepotism and expected but Hunter on a board with former President of Poland Aleksander Kwasniewski should raise more than a few red flags.

https://www.killingmycareer.com/thesociopathi...ase-study/



Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading